-
1
المؤلفون: Willeit, Peter, Tschiderer, Lena, Allara, Elias, Reuber, Kathrin, Seekircher, Lisa, Gao, Lu, Liao, Ximing, Lonn, Eva, Gerstein, Hertzel C, Yusuf, Salim, Brouwers, Frank P, Asselbergs, Folkert W, Van Gilst, Wiek, Anderssen, Sigmund A, Grobbee, Diederick E, Kastelein, John JP, Visseren, Frank LJ, Ntaios, George, Hatzitolios, Apostolos I, Savopoulos, Christos, Nieuwkerk, Pythia T, Stroes, Erik, Walters, Matthew, Higgins, Peter, Dawson, Jesse, Gresele, Paolo, Guglielmini, Giuseppe, Migliacci, Rino, Ezhov, Marat, Safarova, Maya, Balakhonova, Tatyana, Sato, Eiichi, Amaha, Mayuko, Nakamura, Tsukasa, Kapellas, Kostas, Jamieson, Lisa M, Skilton, Michael, Blumenthal, James A, Hinderliter, Alan, Sherwood, Andrew, Smith, Patrick J, Van Agtmael, Michiel A, Reiss, Peter, Van Vonderen, Marit GA, Kiechl, Stefan, Klingenschmid, Gerhard, Sitzer, Matthias, Stehouwer, Coen DA, Uthoff, Heiko, Zou, Zhi-Yong, Cunha, Ana R, Neves, Mario F, Witham, Miles D, Park, Hyun-Woong, Lee, Moo-Sik, Bae, Jang-Ho, Bernal, Enrique, Wachtell, Kristian, Kjeldsen, Sverre E, Olsen, Michael H, Preiss, David, Sattar, Naveed, Beishuizen, Edith, Huisman, Menno V, Espeland, Mark A, Schmidt, Caroline, Agewall, Stefan, Ok, Ercan, Aşçi, Gülay, De Groot, Eric, Grooteman, Muriel PC, Blankestijn, Peter J, Bots, Michiel L, Sweeting, Michael J, Thompson, Simon G, Lorenz, Matthias W, PROG-IMT And The Proof-ATHERO Study Groups
المساهمون: Group, PROG-IMT Study, Group, Proof-ATHERO Study, Vascular Medicine, Medical Psychology, APH - Mental Health, APH - Personalized Medicine, Experimental Vascular Medicine, ACS - Atherosclerosis & ischemic syndromes, Global Health, APH - Aging & Later Life, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, ACS - Pulmonary hypertension & thrombosis, Ege Üniversitesi, MUMC+: Centrum voor Chronische Zieken (3), MUMC+: MA Med Staf Artsass Interne Geneeskunde (9), RS: Carim - V01 Vascular complications of diabetes and metabolic syndrome, MUMC+: HVC Pieken Maastricht Studie (9), Interne Geneeskunde, MUMC+: MA Interne Geneeskunde (3), Allara, Elias [0000-0002-1634-8330], Apollo - University of Cambridge Repository, Cardiovascular Centre (CVC), Internal medicine, Nephrology, ACS - Diabetes & metabolism
المصدر: Willeit, P, Tschiderer, L, Allara, E, Reuber, K, Seekircher, L, Gao, L, Liao, X, Lonn, E, Gerstein, H C, Yusuf, S, Brouwers, F P, Asselbergs, F W, van Gilst, W, Anderssen, S A, Grobbee, D E, Kastelein, J J P, Visseren, F L J, Ntaios, G, Hatzitolios, A I, Savopoulos, C, Nieuwkerk, P T, Stroes, E, Walters, M, Higgins, P, Dawson, J, Gresele, P, Guglielmini, G, Migliacci, R, Ezhov, M, Safarova, M, Balakhonova, T, Sato, E, Amaha, M, Nakamura, T, Kapellas, K, Jamieson, L M, Skilton, M, Blumenthal, J A, Hinderliter, A, Sherwood, A, Smith, P J, van Agtmael, M A, Reiss, P, van Vonderen, M G A, Kiechl, S, Klingenschmid, G, Sitzer, M, Stehouwer, C D A, Uthoff, H, Olsen, M H & PROG-IMT and the Proof-ATHERO Study Groups 2020, ' Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk : Meta-Analysis of 119 Clinical Trials Involving 100 667 Patients ', Circulation, vol. 142, no. 7, pp. 621-642 . https://doi.org/10.1161/CIRCULATIONAHA.120.046361
Circulation, 142(7), 621-642. LIPPINCOTT WILLIAMS & WILKINS
Willeit, P, Tschiderer, L, Allara, E, Reuber, K, Seekircher, L, Gao, L, Liao, X, Lonn, E, Gerstein, H C, Yusuf, S, Brouwers, F P, Asselbergs, F W, Van Gilst, W, Anderssen, S A, Grobbee, D E, Kastelein, J J P, Visseren, F L J, Ntaios, G, Hatzitolios, A I, Savopoulos, C, Nieuwkerk, P T, Stroes, E, Walters, M, Higgins, P, Dawson, J, Gresele, P, Guglielmini, G, Migliacci, R, Ezhov, M, Safarova, M, Balakhonova, T, Sato, E, Amaha, M, Nakamura, T, Kapellas, K, Jamieson, L M, Skilton, M, Blumenthal, J A, Hinderliter, A, Sherwood, A, Smith, P J, Van Agtmael, M A, Reiss, P, Van Vonderen, M G A, Kiechl, S, Klingenschmid, G, Sitzer, M, Stehouwer, C D A, Uthoff, H, Zou, Z Y, Cunha, A R, Neves, M F, Witham, M D, Park, H W, Lee, M S, Bae, J H, Bernal, E, Wachtell, K, Kjeldsen, S E, Olsen, M H, Preiss, D, Sattar, N, Beishuizen, E, Huisman, M V, Espeland, M A, Schmidt, C, Agewall, S, Ok, E, Aşçi, G, De Groot, E, Grooteman, M P C, Blankestijn, P J, Bots, M L, Sweeting, M J, Thompson, S G & Lorenz, M W 2020, ' Carotid intima-media thickness progression as surrogate marker for cardiovascular risk : Meta-Analysis of 119 clinical trials involving 100 667 patients ', Circulation, vol. 142, no. 7, pp. 621-642 . https://doi.org/10.1161/CIRCULATIONAHA.120.046361
Circulation, 142(7), 621-642. Lippincott Williams and Wilkinsمصطلحات موضوعية: Male, medicine.medical_specialty, Carotid Artery, Common, carotid intima-media thickness, LDL TREATMENT STRATEGIES, Myocardial Infarction, surrogate marker, TYPE-2 DIABETES-MELLITUS, HIV-INFECTED PATIENTS, 030204 cardiovascular system & hematology, Impaired glucose tolerance, EXTENDED-RELEASE NIACIN, 03 medical and health sciences, 0302 clinical medicine, IMPAIRED GLUCOSE-TOLERANCE, ESTROGEN PLUS PROGESTIN, cardiovascular disease, Physiology (medical), Internal medicine, BASE-LINE CHARACTERISTICS, medicine, Humans, CORONARY-HEART-DISEASE, 030212 general & internal medicine, Myocardial infarction, cardiovascular diseases, Stroke, Randomized Controlled Trials as Topic, clinical trials as topic, business.industry, Surrogate endpoint, Middle Aged, medicine.disease, Common, Clinical trial, meta-analysis, ARTERIAL-WALL THICKNESS, Intima-media thickness, JAPAN STATIN TREATMENT, Heart Disease Risk Factors, Relative risk, Meta-analysis, Cardiology, cardiovascular system, Female, Carotid Artery, Cardiology and Cardiovascular Medicine, business
وصف الملف: application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b12f6fbaa10360ca86fdbefdaff247d
https://doi.org/10.1161/circulationaha.120.046361 -
2
المؤلفون: Sae-Won Han, Jung Hwan Yoon, Seock-Ah Im, Tae-You Kim, Myoung Jin Jang, Tae Yong Kim, Su Jong Yu, Eun Ju Cho, Do-Youn Oh, Yoon Jun Kim, Kyung-Hun Lee, Jeong Hoon Lee, Dae Won Lee
المصدر: British Journal of Cancer
مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Carcinoma, Hepatocellular, overall survival, surrogate marker, Antineoplastic Agents, chemotherapy, time to progression, Disease-Free Survival, Statistics, Nonparametric, 03 medical and health sciences, 0302 clinical medicine, hemic and lymphatic diseases, Internal medicine, medicine, Humans, Molecular Targeted Therapy, Lung cancer, neoplasms, Proportional Hazards Models, Randomized Controlled Trials as Topic, Surrogate endpoint, business.industry, Proportional hazards model, Liver Neoplasms, Hazard ratio, hepatocellular carcinoma, respiratory system, medicine.disease, Confidence interval, Clinical trial, Treatment Outcome, Clinical Trials, Phase III as Topic, 030220 oncology & carcinogenesis, Hepatocellular carcinoma, Meta-analysis, Clinical Study, Disease Progression, Regression Analysis, 030211 gastroenterology & hepatology, business, Biomarkers